NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Impact of Covid-19 on Syphilis
Impact of Covid-19 on Syphilis

NCT07150871

Active Not RecruitingN/A

Sponsor: Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria

Conditions: Syphilis, COVID - 19, HIV (Human Immunodeficiency Virus), Retrospective Studies

Interventions: Patients diagnosed with syphilis

Countries: Italy

Sexually transmitted infections (STIs) represent a significant challenge to global public health. Although many of these infections are treatable, failure to diagnose and delayed treatment can lead to serious complications, including infertility, chronic inflammatory diseases, and an increased risk of HIV transmission. The COVID-19 pandemic has had a significant impact on healthcare management, the economy, and citizens' lifestyles. The first lockdown in the spring of 2020 affected the entire country, while in the following months, government measures were differentiated on a regional basis, with varying restrictions on activities and mobility. Physical distancing, the use of personal protective equipment, fear of contagion, and health restrictions contributed to a delay in STI diagnoses, resulting in an increase in transmission and severity of cases diagnosed after 2022.

Eligibility overview

Sex: ALL

Age: 18 Years to

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria
Inclusion Criteria:

* Patients aged ≥18 years
* Patients with microbiological and/or clinical diagnosis of syphilis
* Patients treated by the Infectious Diseases Department of the University Hospital of Alessandria
* Signature of informed consent form

Exclusion Criteria:

* Patients for whom the data required for the study are not available in medical records or electronic filing systems
Locations (1)
  • Alessandria, Piedmont, Italy